(Q38394841)

2 September 2017

Toward a working definition of C3 glomerulopathy by immunofluorescence (English)

1 reference

immunofluorescence microscopy

2 September 2017

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24067430%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

author name string

Jean Hou

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24067430%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Glen S Markowitz

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24067430%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Andrew S Bomback

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24067430%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Gerald B Appel

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24067430%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

M Barry Stokes

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24067430%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Vivette D D'Agati

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24067430%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

language of work or name

English

0 references

publication date

25 September 2013

1 reference

2 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24067430%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

volume

85

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24067430%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

page(s)

450-456

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24067430%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24067430%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/ki.2013.340

14 June 2020

exact match

0 references

cites work

Immunopathology of membranoproliferative glomerulonephritis with subendothelial deposits (Type I MPGN)

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.340

7 January 2021

Dense deposit disease: a variant of membranoproliferative glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.340

7 January 2021

Dense deposit disease is not a membranoproliferative glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.340

7 January 2021

C3 glomerulonephritis: clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.340

7 January 2021

Membranoproliferative glomerulonephritis: pathogenetic heterogeneity and proposal for a new classification

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.340

7 January 2021

C3 glomerulopathy: a new classification

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.340

7 January 2021

C3 deposition glomerulopathy due to a functional factor H defect

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.340

7 January 2021

Allelic variants of complement genes associated with dense deposit disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.340

7 January 2021

Anti-factor B autoantibody in dense deposit disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.340

7 January 2021

Factor H autoantibodies in membranoproliferative glomerulonephritis.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.340

7 January 2021

Significance of C3 nephritic factor (C3NeF) in non-hypocomplementaemic serum with membranoproliferative glomerulonephritis (MPGN).

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.340

7 January 2021

Glomeruli of Dense Deposit Disease contain components of the alternative and terminal complement pathway

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.340

7 January 2021

Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.340

7 January 2021

Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.340

7 January 2021

Pathogenesis of the C3 glomerulopathies and reclassification of MPGN.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.340

7 January 2021

Treatment options for C3 glomerulopathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.340

7 January 2021

Familial C3 glomerulopathy associated with CFHR5 mutations: clinical characteristics of 91 patients in 16 pedigrees

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.340

7 January 2021

Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.340

7 January 2021

C3 glomerulopathy: what's in a name?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.340

7 January 2021

C3 glomerulopathy masquerading as acute postinfectious glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.340

7 January 2021

C3 glomerulonephritis associated with monoclonal gammopathy: a case series.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.340

7 January 2021

Pathology after eculizumab in dense deposit disease and C3 GN.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.340

7 January 2021